Oppenheimer Asset Management Inc. Bio N Tech Se Transaction History

Oppenheimer Asset Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$80.36 - $102.87 $1,285 - $1,645	16 Added 0.08%	21,349 $1.72 Million
Q1 2024 May 06, 2024	SELL	$88.96 - $112.35 $111,911 - $141,336	-1,258 Reduced 5.57%	21,333 $1.97 Million
Q4 2023 Feb 13, 2024	BUY	$90.91 - $112.75 $2.05 Million - $2.55 Million	22,591 New	22,591 $2.38 Million
Q1 2022 May 12, 2022	SELL	$126.25 - $231.85 $194,551 - $357,280	-1,541 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$216.64 - $362.52 $333,842 - $558,643	1,541 New	1,541 $397,000

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $29.3B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.